Altered sialylation of alveolar macrophages in HIV-1-infected individuals

被引:0
|
作者
Perrin, C
Giordanengo, V
Bannwarth, S
Blaive, B
Lefebvre, JC
机构
[1] FAC MED NICE, VIROL LAB, F-06107 NICE 2, FRANCE
[2] FAC MED NICE, SERV PNEUMOL, NICE, FRANCE
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1997年 / 110卷 / 01期
关键词
alveolar macrophage; HIV; sialic acid;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In previous studies, we have demonstrated that O-glycans at the surface of HIV-1-infected cell lines were hyposialylated. Moreover. we and others have shown that HIV+ individuals produced autoantibodies that react with hyposialylated CD43, on T cell lines. Since the autoantigen responsible for this abnormal immune response was not easily found in the peripheral blood cells of corresponding patients, we searched for its possible presence in other sites. Using fluorescence staining of alveolar macrophages with various lectins, we show that the binding of the PNA lectin specific for asialo O-glycans is much more efficient on cells from HIV-1-infected individuals. Moreover, the degree of reactivity of PNA Is correlated with the clinical stage of the illness.
引用
收藏
页码:22 / 25
页数:4
相关论文
共 50 条
  • [21] Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy
    Terry, L
    Sprinz, E
    Stein, R
    Medeiros, NB
    Oliveira, J
    Ribeiro, JP
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2006, 38 (03): : 411 - 417
  • [22] Memory B cell dysregulation in HIV-1-infected individuals
    Carrillo, Jorge
    Negredo, Eugenia
    Puig, Jordi
    Manuel Molinos-Albert, Luis
    Luisa Rodriguez de la Concepcion, Maria
    Curriu, Marta
    Massanella, Marta
    Navarro, Jordi
    Crespo, Manel
    Vinets, Ester
    Milla, Fuensanta
    Clotet, Bonaventura
    Blanco, Julia
    AIDS, 2018, 32 (02) : 149 - 160
  • [23] Metabolic characterization of plasma samples in HIV-1-infected individuals
    Zhang, Ting
    Sun, Jianping
    Du, Haiwei
    Su, Haoxiang
    Zhang, Yonghong
    Jin, Qi
    FUTURE MICROBIOLOGY, 2018, 13 (09) : 985 - 996
  • [24] Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy
    Gradoni, L
    Scalone, A
    Gramiccia, M
    Troiani, M
    AIDS, 1996, 10 (07) : 785 - 791
  • [25] PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1 BY ALVEOLAR MACROPHAGES FROM HIV-1-INFECTED PERSONS
    COX, RA
    ANDERS, GT
    CAPPELLI, PJ
    JOHNSON, JE
    BLANTON, HM
    SEAWORTH, BJ
    TREASURE, RL
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (04) : 431 - 441
  • [26] Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages
    Moorjani, H
    Craddock, BP
    Morrison, SA
    Steigbigel, RT
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (01): : 18 - 22
  • [27] Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome
    Grima, Pierfrancesco
    Guido, Marcello
    Chiavaroli, Roberto
    Stano, Francesca
    Tundo, Paolo
    Tana, Mariangela
    de Donno, Antonella
    Zizza, Antonella
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (02) : 133 - 137
  • [28] Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages
    Jiang, ZG
    Piggee, C
    Heyes, MP
    Murphy, C
    Quearry, B
    Bauer, M
    Zheng, J
    Gendelman, HE
    Markey, SP
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 117 (1-2) : 97 - 107
  • [29] Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages
    Kerr, SJ
    Armati, PJ
    Pemberton, LA
    Smythe, G
    Tattam, B
    Brew, BJ
    NEUROLOGY, 1997, 49 (06) : 1671 - 1681
  • [30] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    David J. Back
    Andrew Owen
    Saye H. Khoo
    Clinical Pharmacokinetics, 2006, 45 : 213 - 214